Moore's Compounding Pharmacy Recalls Levothyroxine/Liothyronine Capsules for Potency Failures
Moore's Compounding Pharmacy is recalling Levothyroxine Sodium/Liothyronine SR capsules due to superpotent and subpotent potency failures.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the rubric specifies that FDA Class II recalls with significant injury/property-damage reports or structural defects are Severe. While no injuries are explicitly reported, the agency's Class II classification for a potent thyroid medication with potency failures aligns with the Severe tier in the absence of Class I indicators.
Plain-English summary
Moore's Compounding Pharmacy in Corpus Christi, Texas, is recalling Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles. The recall is due to potency failures where the medication was found to be superpotent (too strong) or subpotent (too weak).
The affected product is prescription-only and was distributed in Texas. The specific lot code is 2016-08-22:37@28 with an expiration date of 2/18/2017.
Patients who have this medication should contact their healthcare provider or pharmacist for guidance on what to do next.
The recalled product
- Product
- Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy Compounding, Corpus Christi, TX
- Manufacturer
- MOORE'S COMPOUNDING PHARMACY
- Category
- Drug — Thyroid Medication
- Hazard
- Affected units
- 90
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 2016-08-22:37@28
- exp 2/18/2017
Distribution
Distributed in 1 state:
Related recalls
Same hazard · potency failure
See all →- Moderateglo Skin Beauty Remedy Gel recalled as a subpotent hydrocortisone product
FDA (Drugs) · 2026-04-22
- ModerateRhonda Allison calming skin gel recalled as a subpotent hydrocortisone product
FDA (Drugs) · 2026-04-22
- ModerateAvantor magnesium chloride active pharmaceutical ingredient recalled as subpotent
FDA (Drugs) · 2026-04-22
- ModerateSkin Rehab calming hydrocortisone balm recalled as a subpotent drug
FDA (Drugs) · 2026-04-22
- HighTeva isotretinoin 40 mg capsules recalled as superpotent and subpotent
FDA (Drugs) · 2026-04-15
Similar recalls
- HighLevothyroxine Sodium Tablets Recalled Due to Potency Failures
FDA (Drugs) · 2024-12-18
- HighLevothyroxine Sodium Tablets recalled nationwide for potency failures
FDA (Drugs) · 2024-12-18
- HighLevothyroxine sodium tablets recalled for potency failures nationwide
FDA (Drugs) · 2024-12-18
- HighLevothyroxine Sodium Tablets Recalled for Potency Variation and Dosage Failures
FDA (Drugs) · 2024-12-18
- SevereMajor Pharmaceuticals Recalls Levothyroxine Sodium Tablets Over Subpotency
FDA (Drugs) · 2026-07-29
- HighLevothyroxine Sodium Tablets Recalled Due to Subpotency Nationwide
FDA (Drugs) · 2024-12-11